Advantages of Continuous-Valued Risk Scores for Predicting Long-Term Costs: The Framingham Coronary Heart Disease 10-Year Risk Score

Sarah Y. Zheng; Benjamin Lubin; Rhoda Au; Joanne M. Murabito; Emelia Benjamin; Michael Shwartz

doi:10.20900/agmr20190004

Back

Advantages of Continuous-Valued Risk Scores for Predicting Long-Term Costs: The Framingham Coronary Heart Disease 10-Year Risk Score

Article 2019 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2008

A Risk Score for Predicting Near-Term Incidence of Hypertension: The Framingham Heart Study

Nisha I. Parikh, Michael Pencina, Thomas J. Wang, Emelia Benjamin, Katherine J. Lanier, Daniel Levy, Ralph B. D’Agostino, William B. Kannel, Ramachandran S. Vasan

Article2015

Abstract 12125: The CHARGE-AF Risk Score Performs Better at Predicting Risk of Atrial Fibrillation than the CHA2DS2-VASc Risk Score in the Framingham Heart Study

Ingrid E. Christophersen, Xiaoyan Yin, Martin G. Larson, Steven A. Lubitz, Jared W. Magnani, David D. McManus, Patrick T. Ellinor, Emelia Benjamin

Article2015

Abstract 13168: Food Quality Score and the Risk of Coronary Heart Disease

Teresa T. Fung, An Pan, Tao Hou, Dariush Mozzafarian, Shilpa N. Bhupathiraju, Walter C. Willett, Frank B Hu

Article1990

Left Main Coronary Angioplasty: Assessment of a “Risk Score” to Predict Acute and Long‐Term Outcome

Michel Samson, Sylvain Planté, Hannie J Meester, Benno J. Rensing, Pim J. de Feyter, Patrick W. Serruys

Journal of Interventional Cardiology

Article2011

The SYNTAX Score and SYNTAX-Based Clinical Risk Scores

Vasim Farooq, Salvatore Brugaletta, Patrick W. Serruys

Seminars in Thoracic and Cardiovascular Surgery